Evaluation of contingency management as a strategy to improve HCV linkage to care and treatment in persons attending needle and syringe programs
A pilot study
Datos Bibliográficos
| ID | 14909477 |
|---|---|
| Autores | Brianna L Norton (0000-0002-8287-2245, Montefiore Medical Center, autor de correspondencia), Marcus A Bachhuber (0000-0002-5610-8382, Montefiore Medical Center), R Singh (0000-0003-1755-6163, New York University), Linda Agyemang (0000-0002-0784-0235, Montefiore Medical Center), Julia H Arnsten (0000-0002-7741-1567, Montefiore Medical Center), Chinazo O Cunningham (0000-0002-7930-313X, Montefiore Medical Center), Alain H Litwin (0000-0002-6717-0288, Montefiore Medical Center, autor de correspondencia) |
| Año | 2019 |
| Volumen | 69 |
| Páginas | 1-7 |
| Fecha de publicación | 2019-07-01 |
| Peer Reviewed | Sí |
| Open Access | Sí |
| Tipo | ARTICLE |
| Revista | International Journal of Drug Policy (JOURNAL) |
| Identificadores de la revista | ISSN: 0955-3959 • E-ISSN: 1873-4758 |
| Editorial | Elsevier BV (PUBLISHER) |
| DOI | 10.1016/j.drugpo.2019.02.009 |
| PMID | 31003171 |
| OpenAlex | W2936328581 |
| Idioma | EN |
| Citas recibidas | 7 |
| Referencias citadas | 48 |
Contingency · Contingency management · Family medicine · Linkage (software · Medical emergency · Psychiatry · Syringe · Hepatitis B Virus Studies · Hepatitis C virus research · HIV, Drug Use, Sexual Risk · Medicine · Nursing · Psychology
Cupping a solution
Effectiveness of periodic incentives on clinic attendance and hepatitis C testing and treatment for people who inject drugs
Utilising an access to care integrated framework to explore the perceptions of hepatitis C treatment of hospital-based interventions among people who use drugs
Evaluation of the Xpert HCV VL Fingerstick point-of-care assay and dried blood spot HCV-RNA testing as simplified diagnostic strategies among people who inject drugs in Catalonia, Spain
Financial incentives to increase engagement across the hepatitis C care cascade among people at risk of or diagnosed with hepatitis C
Interventions to increase linkage to care and adherence to treatment for hepatitis C among people who inject drugs
Peer outreach point-of-care testing as a bridge to hepatitis C care for people who inject drugs in Toronto, Canada
Global, regional, and country‐level estimates of hepatitis C infection among people who have recently injected drugs
Conditional Cash Transfers for Improving Uptake of Health Interventions in Low- and Middle-Income Countries
Syringe Service Programs for Persons Who Inject Drugs in Urban, Suburban, and Rural Areas — United States, 2013
The fifth edition of the addiction severity index
Epidemiology and natural history of HCV infection
Hepatitis C virus treatment for prevention among people who inject drugs
Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs
High HCV cure rates for people who use drugs treated with direct acting antiviral therapy at an urban primary care clinic
Estimating the cascade of hepatitis C testing, care and treatment among people who inject drugs in Australia
Seroprevalence of HCV and HIV infection among clients of the nation’s longest-standing statewide syringe exchange program
Elimination of hepatitis C virus infection among PWID
Prevention, treatment and care of hepatitis C virus infection among people who inject drugs
Treatment uptake and outcomes among current and former injection drug users receiving directly observed therapy within a multidisciplinary group model for the treatment of hepatitis C virus infection
Hepatitis C transmission and treatment as prevention – The role of the injecting network
Using database linkages to monitor the continuum of care for hepatitis C virus among syringe exchange clients
Interventions to enhance testing, linkage to care and treatment uptake for hepatitis C virus infection among people who inject drugs
Development of the Alcohol Use Disorders Identification Test (Audit)
| Obras citantes distintas | 7 |
|---|---|
| Citas por año | 1,17 |
| Intervalo de citas | 2020 - 2026 (7) |
| Velocidad de citación | current |
| Altamente citado | No |
| Tipos de cita | Neutras: 7 |